Adam RollinsDallas has been chosen as the site for a critical new medical hub, marking a significant milestone in a national health innovation network. This network is a central element of a sweeping $2.5 billion initiative led by the Advanced Research Projects Agency for Health (ARPA-H). As a federal agency, ARPA-H is renowned for its role in funding groundbreaking medical and scientific research.
The Dallas hub will focus on advancing a range of critical areas in healthcare, including clinical trials, health outcomes measurement, advanced manufacturing, human-centered design, testing, evaluation and data integration. This selection places Dallas at the forefront of healthcare innovation, poised to make significant contributions to medical science and patient care.
Pegasus Park, a 23-acre campus boasting over 750,000 square feet of office space, has been chosen as the location for this state-of-the-art facility. This selection not only highlights Dallas’s growing influence in the healthcare sector but also promises to bring substantial economic and social benefits to the region.
This development is the outcome of a strategic multi-city bid within Texas, involving Dallas, Austin, Houston and San Antonio. Each city played a key role in securing this opportunity, with San Antonio designated as the lead facilitator. The Dallas facility will benefit from San Antonio’s expertise, particularly in creating immersive patient experiences.
The Dallas hub joins other ARPA-H locations in Cambridge, Massachusetts, and Washington, D.C., creating a powerful trifecta in the nationwide health innovation network. This network aims to drive transformative change in the American healthcare landscape, focusing on accessible, equitable and efficient healthcare solutions.
